| Literature DB >> 34880930 |
Georgios Kantidakis1,2,3, Elia Biganzoli4, Hein Putter2, Marta Fiocco1,2,5.
Abstract
BACKGROUND: Studies focusing on prediction models are widespread in medicine. There is a trend in applying machine learning (ML) by medical researchers and clinicians. Over the years, multiple ML algorithms have been adapted to censored data. However, the choice of methodology should be motivated by the real-life data and their complexity. Here, the predictive performance of ML techniques is compared with statistical models in a simple clinical setting (small/moderate sample size and small number of predictors) with Monte-Carlo simulations.Entities:
Mesh:
Year: 2021 PMID: 34880930 PMCID: PMC8646180 DOI: 10.1155/2021/2160322
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.238
Proportions for the 16 unique combinations in the original data with 422 patients. Mean and standard deviation of age at the date of surgery are provided per combination.
| Treatment | Sex | Histological response | Excision | Proportion | Mean age (sd) |
|---|---|---|---|---|---|
| Regimen C | Female | Poor | Unknown/incomplete | 0.02 | 12.05 (4.44) |
| Regimen C | Female | Poor | Complete | 0.12 | 17.04 (7.35) |
| Regimen C | Female | Good | Unknown/incomplete | 0.01 | 11.06 (2.48) |
| Regimen C | Female | Good | Complete | 0.05 | 13.72 (5.17) |
| Regimen C | Male | Poor | Unknown/incomplete | 0.01 | 12.48 (1.30) |
| Regimen C | Male | Poor | Complete | 0.17 | 16.70 (6.93) |
| Regimen C | Male | Good | Unknown/incomplete | 0.02 | 14.30 (2.77) |
| Regimen C | Male | Good | Complete | 0.09 | 16.07 (5.19) |
| Regimen DI | Female | Poor | Unknown/incomplete | 0.01 | 14.60 (2.33) |
| Regimen DI | Female | Poor | Complete | 0.08 | 15.35 (6.24) |
| Regimen DI | Female | Good | Unknown/incomplete | 0.01 | 13.85 (6.12) |
| Regimen DI | Female | Good | Complete | 0.09 | 14.34 (5.49) |
| Regimen DI | Male | Poor | Unknown/incomplete | 0.03 | 15.87 (4.04) |
| Regimen DI | Male | Poor | Complete | 0.14 | 18.54 (6.02) |
| Regimen DI | Male | Good | Unknown/incomplete | 0.01 | 10.63 (2.98) |
| Regimen DI | Male | Good | Complete | 0.14 | 17.11 (5.64) |
Performance of PLANN original and PLANN extended tuned for the IBS at 5 years or the C-index for 61% censoring (scenario 1) and 1000 synthetic patients per dataset. The standard deviation (sd) based on 1000 datasets is provided in parentheses.
| Measure | PLANN original IBS | PLANN original C-index | PLANN extended IBS | PLANN extended C-index |
|---|---|---|---|---|
| Brier score 2 years (sd) | 0.145 (0.012) | 0.146 (0.012) | 0.144 (0.011) | 0.144 (0.011) |
| Brier score 5 years (sd) | 0.229 (0.010) | 0.232 (0.011) | 0.229 (0.011) | 0.230 (0.010) |
| IBS 5 years (sd) | 0.124 (0.007) | 0.125 (0.007) | 0.123 (0.006) | 0.124 (0.007) |
| C-index (sd) | 0.633 (0.022) | 0.628 (0.023) | 0.637 (0.021) | 0.631 (0.024) |
| Miscalibration 2 years (sd) | 0.003 (0.003) | 0.004 (0.003) | 0.003 (0.002) | 0.003 (0.002) |
| Miscalibration 5 years (sd) | 0.006 (0.004) | 0.007 (0.004) | 0.008 (0.006) | 0.006 (0.006) |
Figure 1Brier score for Cox, PLANN original, and PLANN extended±one standard deviation for 61% censoring scenario 1. (a) 250 patients; (b) 1000 patients.
Figure 2Predictive performance for Cox, PLANN original, and PLANN extended for sample sizes 250 and 1000± one standard deviation for 61% censoring scenario 1. (a) C-index; (b) IBS at 5 years.
Figure 3Miscalibration for Cox, PLANN original, and PLANN extended per sample size and 61% censoring (scenario 1). (a) 2 years; (b) 5 years.
Figure 4The predictive performance of PLANN original± one standard deviation for sample size 250 or 1000 and 61% censoring (scenario 1). Darker green palette colours correspond to the 2 adverse scenarios (a) removing patients censored before the second year or (b) curtailing patients' survival at 5 years. (a) C-index; (b) IBS at 5 years.
Figure 5Predictive performance of PLANN extended± one standard deviation for sample size 250 or 1000 and 61% censoring (scenario 1). Darker blue palette colours correspond to the 2 adverse scenarios (a) removing patients censored before the second year or (b) curtailing patients' survival at 5 years. (a) C-index; (b) IBS at 5 years.